Scroll To Top

No Surprise Here: Newer Drugs Last Longer

No Surprise Here: Newer Drugs Last Longer


A new analysis in the journal AIDS has reached a conclusion few will find unexpected -- newer, once-daily, fixed-dose antiretroviral regimens like Epzicom, Atripla, and Truvada are more durable than earlier antiretroviral treatment options. 'Our results indicate this [improved durability is] due to both more convenient dosing and improved tolerability of modern antiretroviral regimens,' they conclude. Prolonging the durability of antiretroviral regimens is critical to achieving long-term treatment success since the medications must be taken indefinitely, the study authors say.

Out Subscription Lil Nas XAdvocateChannel promotion

From our Sponsors

Most Popular

Fifth Person Cured of HIV

Latest Stories